H.S. Ayoub submits: Back on October 23 BioHealth Investor [BHI] recommended H&Q Life Science (HQL) as a great biomedical closed-ended fund to invest in, rather than pick single risky stocks. A few days later, the Alligator Investor made his case against HQL . Did he provide decent points of view? Not really. In fact, the Alligator agreed with BHI on many points, but cited that his intuition says that something is wrong with HQL. Basing your investment decisions on intuition alone is a form of gambling, but that is another argument for another time. Well, on Thursday Jim Fink, writing for The Motley Fool, not only featured HQL as a great healthcare ETF , but chose it as the best ETF for 2007! Complete Story » ...
Anytime
